ArticleInternational journal of endocrinology2026
Comparative Evaluation of Metabolic Syndrome, Circadian Syndrome, and Allostatic Load Measures on All-Cause Mortality in U.S. Males and Females.
Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic stressors, including metabolic syndrome (MetS), circadian syndrome (CircS), and allostatic load (AL), measure the metabolic and stress-related physiological dysregulations that are associated with the risk of frailty and cardiovascular mortality in the adult population. Aim: To assess the effects of MetS, CircS, and AL on all-cause mortality in U.S. adults by age and sex. Methods: We performed a retrospective cohort analysis using the National Health and Nutrition Examination Survey (NHANES) data, including 7 cycles (2005-2018). The associations between metabolic stressors and mortality were evaluated using stratified Cox regression analyses. Results: The study included 37434 adults for analysis of CircS and MetS, while 26480 adults were included for AL analysis. All exposures, including CircS (hazard ratio [HR]: 1.29; 95% confidence interval [CI] 1.18-1.42), MetS (HR: 1.09; 95% CI 1.00-1.18), and AL (HR: 1.25; 95% CI 1.11-1.41), were associated with all-cause mortality in the entire cohort. In adjusted analyses, CircS (HR: 1.55; 95% CI 1.34-1.80), MetS (HR: 1.32; 95% CI 1.14-1.53), and AL (HR: 1.44; 95% CI 1.21-1.70) were only associated with all-cause mortality in individuals with age < 70 years. In subgroup analyses by sex, all three exposures were strongly associated with mortality in males as well as in the subgroup of males with age < 70 years. The CircS was found to be a strong marker for all-cause mortality in individuals aged < 70 and in both sexes. Conclusion: The strength of association between CircS and all-cause mortality was stronger than that of MetS and AL, irrespective of sex. Our findings indicate that metabolic biomarkers, specifically CircS, may help refine risk stratification and prognostic evaluation among adults aged less than 70 years.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.